Government Archives - HIT Leaders and News

Government

Prior Authorization Enters Its Infrastructure Era

The Centers for Medicare & Medicaid Services is using its 2026 proposed rule on interoperability and drug prior authorization to do more than shorten approval timelines.

April 14, 2026

Photo 260384658 © Timon Schneider | Dreamstime.com

CMS Draws a Harder Line on Medicare Advantage

The latest CMS rate notice is easy to misread. On paper, the agency is still increasing payments to Medicare Advantage plans in 2027. In substance, it is drawing a sharper distinction between legitimate clinical risk and revenue built on documentation tactics that have long inflated the program’s economics.

April 6, 2026

Photo 260384678 © Timon Schneider | Dreamstime.com

A Cleaner Chain of Command for Health IT

Administrative reshuffles inside HHS usually land as management trivia. This one does not. The department’s March 31, 2026 decision to return enterprise technology, data, and AI leadership to the Office of the Chief Information Officer while restoring the Office of the National Coordinator for Health Information Technology to a narrower health IT policy role arrives at a point when governance failures are no longer abstract.

April 6, 2026

Photo 230368273 © Monticelllo | Dreamstime.com

The CMS Rule That Finally Targets the Paperwork Nobody Fixed

The latest move from the Centers for Medicare & Medicaid Services will be easy to underestimate because it sounds so administrative. The newly finalized health care claims attachments rule deals with documentation, transaction standards, and electronic signatures, not a flashy care model or a breakthrough therapy. Yet it may prove to be one of the more important healthcare modernization actions in years precisely because it aims at a part of the system that has remained stubbornly primitive long after the industry declared itself digital.

When Fraud Reaches the Exam Room

The federal case against Anchorage rheumatologist Claribel Tan should not be read as a routine fraud prosecution with unusually vivid facts. In a March 17 sentencing release from the U.S. Attorney’s Office for the District of Alaska, the Department of Justice said the scheme involved more than $12.5 million in health care fraud, more than $4.2 million in tax loss, and conduct that stretched across 15 years. What makes the case editorially important is not only the money. It is the allegation that the fraud was built into treatment itself.

CMS Rule Phases Out Fax Machines and Snail Mail

The latest administrative simplification rule from the Centers for Medicare & Medicaid Services may sound like a narrow technical update, but in its final rule fact sheet the agency says it creates the first HIPAA-adopted standards for health care claims attachments and electronic signatures. That makes the policy less about retiring fax machines than about fixing one of healthcare’s oldest operational failures: the messy, manual handoff between clinical documentation and payment.

Caregiver AI Must Earn Its Place in the Home

The launch of the Caregiver AI Prize Competition by the Administration for Community Living under the U.S. Department of Health and Human Services signals a policy shift that matters beyond a single challenge. Federal leaders are no longer treating caregiving technology as a consumer convenience category. The competition frames AI as a potential layer of national caregiving infrastructure, with explicit expectations around responsible use and harm prevention. That framing raises the bar for what counts as a viable solution in the home.

HHS Adds Former U.S. Attorney for Fraud Efforts

The appointment of former U.S. Attorney Scott Brady to the U.S. Department of Health and Human Services (HHS) Office of General Counsel signals a sharp escalation in the agency’s fraud enforcement strategy. Joining General Counsel Mike Stuart, himself a former federal prosecutor, Brady enters HHS amid what leadership calls the most aggressive anti-fraud campaign in the agency’s history. The move reflects a strategic posture shift: from administrative oversight to criminal accountability.

United States Completes WHO Withdrawal

The finalization of the United States’ withdrawal from the World Health Organization (WHO) marks a seismic shift in global health governance, one that exposes critical uncertainties for healthcare leaders, public health systems, and the infrastructure supporting pandemic readiness. While federal leadership characterized the move as a necessary correction to institutional failure, the long-term implications for operational coordination, global surveillance, and regulatory alignment remain unresolved.

Trump’s Healthcare Plan Forces a New Reckoning on Price Transparency

The healthcare policy landscape in the United States has again shifted with the unveiling of former President Donald Trump’s proposed Great Healthcare Plan. While the political context surrounding the proposal may spark predictable partisan reactions, the plan itself raises a deeper, more systemic challenge: how far can, and should, price transparency, consumer-directed benefits, and direct subsidies go in reshaping how healthcare is purchased, priced, and governed?

Kaiser Permanente Settlement Highlights Breakdown in Medicare Advantage Risk Practices

The recent $556 million settlement by Kaiser Permanente affiliates over inflated Medicare Advantage payments underscores a persistent and unaddressed compliance risk embedded within the risk adjustment ecosystem. The allegations point to systemic pressure on physicians to append diagnoses not considered during patient encounters, practices that, if validated, reveal how financial incentives tied to coding can distort clinical records and degrade payer trust.

DEA & HHS Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026

The fourth federal extension of telemedicine prescribing flexibilities for controlled substances offers temporary relief, but not long-term certainty, for healthcare systems navigating hybrid care delivery. The joint decision by the Department of Health and Human Services and the Drug Enforcement Administration to prolong pandemic-era telemedicine allowances through the end of 2026 is framed as a move to protect patients.

Price Transparency Won’t Fix Health Care Until the Data Does

The latest proposed updates to federal price transparency regulations signal a deeper acknowledgment of an uncomfortable truth: health care pricing data is now technically public, but still functionally unusable. The Centers for Medicare & Medicaid Services (CMS), working with the Departments of Labor and Treasury, aims to correct this mismatch by simplifying data formats, reducing redundancies, and making cost tools more accessible. But unless these changes are paired with a broader shift in how price transparency is operationalized across the system, their impact may remain symbolic rather than structural.

AI Ambitions Meet Systemic Barriers in HHS Push for Clinical Adoption

The U.S. Department of Health and Human Services (HHS) has issued a sweeping Request for Information (RFI) to identify how artificial intelligence (AI) can accelerate clinical transformation across the American healthcare system. Framed as a call to harness AI for lower costs and improved care, the initiative invites input on everything from evolving reimbursement frameworks to rethinking regulatory pathways. But beneath the enthusiasm lies a complex set of operational, legal, and ethical dynamics that will shape whether these ambitions translate into scalable realities.

Botox Fraud Case Underscores Persistent Gaps in Medicare Oversight

A newly unsealed federal indictment against a Los Angeles-area physician alleges a $45 million Medicare fraud scheme involving falsified Botox claims, exposing once again the operational vulnerabilities that continue to undermine the integrity of federal health programs. The charges against Dr. Violetta Mailyan include wire fraud and obstruction of justice, centered on billing for procedures that were medically unnecessary or never performed. While the case is still pending, it signals ongoing systemic exposure to high-value, low-detection fraud.